General Pulmonary   

Do you prescribe it universally or based on specific risk factors?

Does your approach differ based on the underlying condition - such as ANCA-associated vasculitis, rheumatoid arthritis, or another autoimmune disease?

Does the severity of asthma play a role in decision making?

Is there a role for booster vaccination and if so, how do you approach the timing when a patient is already on a biologic for immunosuppression?